Showing results (2771-2780 of 4,129) with videos related to
Sort By:
Pageof 413
Human Gene Therapy|July 31, 2020
Induced Liver Regeneration Enhances CRISPR/Cas9-Mediated Gene Repair in Tyrosinemia Type 1Qing-Shuo Zhang, Amita Tiyaboonchai, Sean Nygaard, et al.Human Gene Therapy|August 4, 2020
In Vivo Gene Therapy for Canine SCID-X1 Using Cocal-Pseudotyped Lentiviral VectorYogendra S Rajawat, Olivier Humbert, Savannah M Cook, et al.Human Gene Therapy|August 25, 2020
Systematic Characterization of the Biodistribution of the Oncolytic Virus M1Jing Cai, Wenbo Zhu, Yuan Lin, et al.Human Gene Therapy|August 25, 2020
Adeno-Associated Virus Vector Mobilization, Risk Versus RealityLiujiang Song, R Jude Samulski, Matthew L HirschHuman Gene Therapy|July 14, 2020
Development of a Clinical Candidate AAV3 Vector for Gene Therapy of Hemophilia BHarrison C Brown, Christopher B Doering, Roland W Herzog, et al.Human Gene Therapy|July 14, 2020
Design and Rationale for First-in-Human Phase 1 Immunovirotherapy Clinical Trial of Oncolytic HSV G207 to Treat Malignant Pediatric Cerebellar Brain TumorsJoshua D Bernstock, Asim K Bag, John Fiveash, et al.Human Gene Therapy|August 1, 2020
Aspects of Gene Therapy Products Using Current Genome-Editing Technology in JapanTeruhide Yamaguchi, Eriko Uchida, Takashi Okada, et al.Human Gene Therapy|April 4, 2015
Cystic Fibrosis Gene Therapy in the UK and ElsewhereUta Griesenbach, Kamila M Pytel, Eric W F W AltonHuman Gene Therapy|April 16, 2021
Preclinical Safety Evaluation of a Recombinant Plasmid Vector Encoding Mature Human Neutrophil Peptide-1 by Repeated Local Administrations in Nonhuman PrimatesDan Li, Fuchun Guo, Ke Chen, et al.Human Gene Therapy|July 17, 2008
RNA interference-mediated in vivo silencing of fas ligand as a strategy for the enhancement of DNA vaccine potencyBruce Huang, Chih-Ping Mao, Shiwen Peng, et al.Pageof 413